Metabolic Disease
| 3 min read
A new compound, Vykat XR, addresses insatiable hunger in the rare genetic condition, offering relief for patients and hope for families.
| 3 min read
A new method for tracking dietary intake used DNA in stool to detect nutritional content from a broad range of foods.
By offering a rich source of insights into disease and drugs, metabolite biomarkers are at the forefront of therapeutic exploration.
| 10+ min read
GLP-1 agonists have transformed the treatment of type 2 diabetes and obesity, but they come with side effects. Physicians say the benefits outweigh the risks.
| 4 min read
Targeting a gut bacterial species or its metabolites could potentially improve diabetes management by reducing sugar preferences.
| 3 min read
Sagimet’s denifanstat delivered significant improvements in disease activity and fibrosis for patients with metabolic dysfunction-associated steatohepatitis.
| 3 min read
Injectable micelles that release glucagon could provide a new way to treat hypoglycemic events in diabetes.
| 10 min read
Customizable hydrogels could make taking diabetes and cancer medications as well as other biologics easier for patients.
| 2 min read
AMSBIO has launched a glucagon-like peptide 1 receptor (GLP-1R) reporter cell line.
| 3 min read
Specialized cells in omental adipose tissue may repress fat cell development.
| 5 min read
Paolo Martini leads the biotech company’s rare disease research program with the hope of developing the very first treatments for genetic metabolic disorders.
| 10 min read
With some out-of-the-box engineering, researchers have developed a nature-inspired strategy to turn sugar in packaged foods into gut-healthy fiber.
| 8 min read
Scientists have appreciated the roles of bacteria in our microbiomes for decades. Now, they’re studying the effects of the trillions of viruses that call the human body home.
| 3 min read
High resolution microscopy revealed distinct mitochondrial populations in inner ear hair cells, setting the stage for probing their role in mitochondrial deafness.
| 6 min read
A new oral bead technology is designed to stimulate nutrient-sensing cells in discrete parts of the gut to restore metabolic balance.
| 6 min read
Mitchell Lazar studies the transcription factors linking circadian disruption to obesity and diabetes.
| 3 min read
A new study suggests that an extra cup of joe may help people survive longer with prostate cancer if they are fast caffeine metabolizers.
Available on Demand
An innovative device decentralizes blood collection and unlocks a new horizon for blood-based biomarker discovery.
| 2 min read
The words “diet” and “exercise” are synonymous with weight loss. Researchers now think that “pharmacotherapy” should be too.
| 4 min read
Implanting brown fat into mice fed a high fat diet helps them lose weight and become glucose tolerant. Will it do the same for humans?
Page 1 of 2 - 29 Total Items
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
Explained: How are metabolite biomarkers improving drug discovery and development?
By offering a rich source of insights into disease and drugs, metabolite biomarkers are at the forefront of therapeutic exploration.
GLP-1R reporter cell line for diabetes / obesity research
AMSBIO has launched a glucagon-like peptide 1 receptor (GLP-1R) reporter cell line.
Simplifying Blood-Based Research
An innovative device decentralizes blood collection and unlocks a new horizon for blood-based biomarker discovery.
